Yelena Kisel, NP
Family · Worcester, MANPI 1619201654
Payments from drug & device makers
Across 1,242 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Johnson & Johnson$3K
- Lilly USA, LLC$2K
- UCB, Inc.$2K
- Novartis$2K
- Amgen$1K
- plus $10K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 208 | $4,303 |
| Johnson & Johnson | 139 | $3,221 |
| Lilly USA, LLC | 100 | $2,444 |
| UCB, Inc. | 107 | $2,099 |
| Novartis | 108 | $1,813 |
| Amgen | 60 | $1,238 |
| Regeneron Healthcare Solutions, Inc. | 50 | $1,218 |
| E.r. Squibb & Sons, L.L.C. | 54 | $1,067 |
| Incyte Corporation | 52 | $1,034 |
| Galderma Laboratories, L.p. | 48 | $906 |
| Sun Pharmaceutical Industries Inc. | 50 | $877 |
| Sanofi | 36 | $855 |
| Dermavant Sciences, Inc. | 33 | $825 |
| Pfizer | 40 | $781 |
| Arcutis Biotherapeutics, Inc. | 59 | $698 |
| LEO Pharma Inc. | 38 | $551 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 16 | $326 |
| Sanofi-aventis U.S. LLC | 3 | $230 |
| Mission Pharmacal Company | 10 | $155 |
| Boehringer Ingelheim | 5 | $130 |
| Janssen Scientific Affairs, LLC | 1 | $114 |
| VYNE Pharmaceuticals Inc. | 7 | $114 |
| Organon | 4 | $86 |
| Sandoz | 5 | $84 |
| Biofrontera Inc. | 3 | $56 |
| Botanix SB Inc | 2 | $48 |
| Fresenius Kabi USA, LLC | 2 | $30 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $20 |
| Dermira, Inc. | 1 | $18 |
How this compares
$25,341 in reported general payments places this provider in the 95th percentile of 2,320 family providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Worcester
- Raichel TopaleWorcester$18K
- Lorraine LoretzWorcester$11K
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Courtney NixonAmherst$81K
- Elizabeth WalshBrighton$80K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.